Literature DB >> 9176085

Effect of chronic endogenous hypergastrinaemia on pancreatic growth and carcinogenesis in the hamster.

M Chu1, E Kullman, J F Rehfeld, K Borch.   

Abstract

BACKGROUND: To examine the effect of gastrin on spontaneous and induced pancreatic carcinogenesis in the hamster. METHODS AND
RESULTS: Two sets of experiments were carried out, one involving long term hypergastrinaemia and one involving cancer induction during hypergastrinaemia. The effect of hypergastrinaemia accomplished by gastric fundectomy was studied for eight months. Neither fundectomised hamsters nor sham operated controls developed premalignant or malignant pancreatic lesions. In the fundectomy group, the mean pancreatic weight, total protein content, and DNA content was increased by 28%, 25%, and 25% respectively. No such increases were found in fundectomised animals receiving a cholecystokinin-B receptor antagonist during the last 24 days of the experiment. In the cancer induction study, the effect of fundectomy on N-nitrosobis(2-oxopropyl) amine induced pancreatic carcinogenesis was studied for three months. There were no significant differences in the incidence or [3H]-thymidine labelling index of focal pancreatic lesions between fundectomised and sham operated control animals.
CONCLUSIONS: Fundectomy with chronic hypergastrinaemia induces pancreatic hypertrophy, but does not enhance N-nitrosobis (2-oxopropyl)amine induced pancreatic carcinogenesis in the hamster. The increases in growth were inhibited by a cholecystokinin-B receptor antagonist, indicating that the trophic effect of fundectomy is mediated by gastrin.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9176085      PMCID: PMC1089284          DOI: 10.1136/gut.40.4.536

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  44 in total

1.  Evaluation of a radioimmunoassay for cholecystokinin in human plasma.

Authors:  P Cantor
Journal:  Scand J Clin Lab Invest       Date:  1986-05       Impact factor: 1.713

2.  Hypergastrinaemia produces trophic effects in stomach but not in pancreas and intestines.

Authors:  R Håkanson; H Blom; E Carlsson; H Larsson; B Ryberg; F Sundler
Journal:  Regul Pept       Date:  1986-02

3.  Additive interaction of pentagastrin and secretin on pancreatic growth in rats.

Authors:  T E Solomon; J Morisset; J G Wood; L J Bussjaeger
Journal:  Gastroenterology       Date:  1987-02       Impact factor: 22.682

4.  Radioimmunoassay of cholecystokinin in human plasma.

Authors:  D J Byrnes; L Henderson; T Borody; J F Rehfeld
Journal:  Clin Chim Acta       Date:  1981-03-19       Impact factor: 3.786

5.  Receptors for cholecystokinin and gastrin peptides display specific binding properties and are structurally different in guinea-pig and dog pancreas.

Authors:  D Fourmy; A Zahidi; R Fabre; M Guidet; L Pradayrol; A Ribet
Journal:  Eur J Biochem       Date:  1987-06-15

6.  Long-term comparative effect of cholecystokinin and gastrin on mouse stomach, antrum, intestine, and exocrine pancreas.

Authors:  D Balas; F Senegas-Balas; L Pradayrol; J Vayssette; C Bertrand; A Ribet
Journal:  Am J Anat       Date:  1985-09

7.  Novel expression of gastrin (CCK-B) receptors in pancreatic carcinomas and dysplastic pancreas from transgenic mice.

Authors:  S P Povoski; W Zhou; D S Longnecker; R H Bell
Journal:  Am J Surg       Date:  1994-01       Impact factor: 2.565

8.  Early lesions during pancreatic carcinogenesis induced in Syrian hamster by DHPN or DOPN. I. Histologic, histochemical and radioautographic findings.

Authors:  M A Moore; M Takahashi; N Ito; P Bannasch
Journal:  Carcinogenesis       Date:  1983       Impact factor: 4.944

9.  Characterization of a 4-month protocol for the quantitation of BOP-induced lesions in hamster pancreas and its application in studying the effect of dietary fat.

Authors:  R A Woutersen; A van Garderen-Hoetmer; D S Longnecker
Journal:  Carcinogenesis       Date:  1987-06       Impact factor: 4.944

10.  Current knowledge of pancreatic carcinogenesis in the hamster and its relevance to the human disease.

Authors:  P M Pour; R G Runge; D Birt; R Gingell; T Lawson; D Nagel; L Wallcave; S Z Salmasi
Journal:  Cancer       Date:  1981-03-15       Impact factor: 6.860

View more
  4 in total

1.  Randomized prospective trial of the effect of induced hypergastrinemia on the prevention of pancreatic atrophy after pancreatoduodenectomy in humans.

Authors:  Jin-Young Jang; Sun-Whe Kim; Joon-Koo Han; Sang-Jae Park; Youn-Chan Park; Young Joon Ahn; Yong-Hyun Park
Journal:  Ann Surg       Date:  2003-04       Impact factor: 12.969

2.  Endogenous gastrin stimulates regeneration of remnant pancreas after partial pancreatectomy.

Authors:  S W Kim; K H Kim; S J Park; H H Her; J Y Jang; Y H Park
Journal:  Dig Dis Sci       Date:  2001-10       Impact factor: 3.199

3.  Proton pump inhibitors on pancreatic cancer risk and survival.

Authors:  Malcolm D Kearns; Ben Boursi; Yu-Xiao Yang
Journal:  Cancer Epidemiol       Date:  2017-01-02       Impact factor: 2.984

4.  Proton pump inhibitors and histamine-2-receptor antagonists and pancreatic cancer risk: a nested case-control study.

Authors:  M C Bradley; L J Murray; M M Cantwell; C M Hughes
Journal:  Br J Cancer       Date:  2011-11-22       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.